Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis

A Study of GB261 in Systemic Sclerosis

NCT07159009 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants

NCT02641041 ·Status: COMPLETED ·Phase: PHASE1

A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting

NCT03589105 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of Natalizumab (BG00002) Administered Subcutaneously to Japanese Participants With Relapsing-Remitting Multiple Sclerosis

NCT05265728 ·Status: TERMINATED ·Phase: PHASE3

Safety Study of BIIB033 in Subjects With Multiple Sclerosis

NCT01244139 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis

NCT00219908 ·Status: TERMINATED ·Phase: PHASE2

Effect of MD1003 in Spinal Progressive Multiple Sclerosis

NCT02220933 ·Status: UNKNOWN ·Phase: PHASE3

Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)

NCT00559702 ·Status: COMPLETED ·Phase: PHASE1

12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients

NCT00616733 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis

NCT06395909 ·Status: COMPLETED

Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis

NCT04777539 ·Status: COMPLETED

Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis

NCT00200655 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple Sclerosis

NCT05064436 ·Status: TERMINATED ·Phase: PHASE1

Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis

NCT01071512 ·Status: COMPLETED ·Phase: NA

A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis

NCT06396039 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)

NCT06675864 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Oral Guanabenz for Multiple Sclerosis

NCT02423083 ·Status: TERMINATED ·Phase: PHASE1

Open-label Study of Liothyronine in MS

NCT02506751 ·Status: COMPLETED ·Phase: PHASE1

A Study of End of Dose Phenomena in Subcutaneous Natalizumab Treated Multiple Sclerosis (MS) Participants

NCT05701423 ·Status: TERMINATED

Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine

NCT00203099 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Safety and Efficacy Study of Peginterferon Beta-1a

NCT01332019 ·Status: COMPLETED ·Phase: PHASE3

Senolytics for Secondary Progressive MS

NCT07270120 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS)

NCT00537082 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis

NCT06220669 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study Evaluating CCI-779 in Relapsing Multiple Sclerosis

NCT00228397 ·Status: COMPLETED ·Phase: PHASE2